Results 21 to 30 of about 6,464 (211)

Evaluation of the in vitro Activity and in vivo Efficacy of Anidulafungin-Loaded Human Serum Albumin Nanoparticles Against Candida albicans

Frontiers in Microbiology, 2021
Recent decades have seen a significant increase in invasive fungal infections, resulting in unacceptably high mortality rates. Anidulafungin (AN) is the newest echinocandin and appears to have several advantages over existing antifungals.
Yu Zhang, Yan-Chao Liu, Yan-Chao Liu, Si-Min Chen, Hui Zong, Wei-Tong Hou, Xi-Ran Qiu, Shi-Yu Guo, Yu-Fang Sun, Yuan-Ying Jiang, Mao-Mao An, Hui Shen   +11 more
doaj   +1 more source

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication

BMC Infectious Diseases, 2018
Background To compare the risk of severe hepatotoxicity with anidulafungin versus caspofungin and micafungin in hospitalized adults. Methods This retrospective cohort study combined data from two large US- based hospital electronic medical record ...
Francis Vekeman, Lisa Weiss, Jalal Aram, Raluca Ionescu-Ittu, Shahrzad Moosavi, Yongling Xiao, Wendy Y. Cheng, Rachel H. Bhak, Margaret Tawadrous, M. Rita Capparella, Philippe Montravers, Mei Sheng Duh   +11 more
doaj   +1 more source

Isolation, identification and characterization of potential impurities of anidulafungin [PDF]

, 2017
Eight impurities ranging from 0.03 to 0.97% in anidulafungin bulk drug were detected by HPLC. Four impurities (Imp-I, Imp-II, Imp-III and Imp-VIII) among impurities were isolated from the self-prepared or marketed samples of anidulafungin bulk drug by ...
Bie, Y, Lu, XX (reprint author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Peoples R China., Wang, QL, Lu, XX, Zhao, LN   +4 more
core   +1 more source

Does Weight Impact Anidulafungin Pharmacokinetics? [PDF]

, 2016
Contains fulltext : 172336.pdf (Publisher’s version ) (Open Access)Bodyweight has been shown to influence anidulafungin exposure, but data from obese patients are lacking. We determined anidulafungin pharmacokinetics (100-mg single dose)
Vincent J. Lempers, Roger J. Brüggemann, Rob E. Aarnoutse, Knibbe, C.A., Lempers, V.J., Knibbe, C.A.J., Bert van Ramshorst, Eric P. van Dongen, Burger, D.M., Rongen, A. van, Rongen, A., Dongen, E.P. Van, Bruggemann, R.J., Anne van Rongen, Ramshorst, B. van, David M. Burger, Aarnoutse, R.E., Lempers, V.J.C., Bruggemann, R.J.M., Catherijne A. Knibbe   +19 more
core   +1 more source

Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.

PLoS ONE, 2019
ObjectiveThe aims of this study were as follows. First, we sought to compare the in vitro susceptibility of liposomal amphotericin B (LAmB) and anidulafungin on Candida albicans and Candida glabrata biofilms growing on silicone discs.
Jana Basas, Marta Palau, Xavier Gomis, Benito Almirante, Joan Gavaldà   +4 more
doaj   +1 more source

SRSF5‐Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host‐Directed Target Against Influenza Virus

Advanced Science, 2022
Splicing of influenza A virus (IAV) RNA is an essential process in the viral life cycle that involves the co‐opting of host factors. Here, it is demonstrated that induction of host serine and arginine‐rich splicing factor 5 (SRSF5) by IAV facilitated ...
Qiuchen Li, Zhimin Jiang, Shuning Ren, Hui Guo, Zhimin Song, Saini Chen, Xintao Gao, Fanfeng Meng, Junda Zhu, Litao Liu, Qi Tong, Honglei Sun, Yipeng Sun, Juan Pu, Kin‐Chow Chang, Jinhua Liu   +15 more
doaj   +1 more source

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature

European Journal of Medical Research, 2011
Echinocandins represent the newest class of antifungal agents. Currently, three echinocandins, anidulafungin, caspofungin and micafungin are licensed for clinical use in various indications.
Kofla G, Ruhnke M
doaj   +1 more source

Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction

Frontiers in Genetics, 2022
Drug repositioning continues to be the most effective, practicable possibility to treat COVID-19 patients. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus enters target cells by binding to the ACE2 receptor via its spike (S ...
Shahzaib Ahamad, Hashim Ali, Hashim Ali, Ilaria Secco, Mauro Giacca, Mauro Giacca, Mauro Giacca, Dinesh Gupta   +7 more
doaj   +1 more source

Safety, efficacy and pharmacokinetics of anidulafungin in patients 1 month to <2 years of age with Invasive candidiasis, including candidemia [PDF]

, 2020
Nineteen patients 1 month to <2 years of age with (n = 16) or at high risk of (n = 3) invasive candidiasis received anidulafungin for 5-35 days (3 mg/kg day 1, 1.5 mg/kg daily thereafter) followed by optional fluconazole (NCT00761267).
Roilides E., Sandra Arnold, Joan Robinson, Fabio Motta, Cheng-Hsun Chiu, Yan J. L., Audra Deveikis, Jong Jin Seo, William Steinbach, Tawadrous M., Nelson Horigoshi, Brian Patrick Lee, Aram J. A., Chuhl Joo Lyu, Rainer Gedeit, Raber S., Jaime Deville, Antonio Arrieta, Queiroz-Telles F. The Anidulafungin A8851008 Pediatric Study Group members are as follows: Natalia Dmitrieva, Carlesse F., Conte U., Leister-Tebbe H., Vassiliki Syriopoulou, Swanson R., Giuseppe Gentile, Richard Grundy, Irina Shipitsina   +26 more
core   +1 more source

Comparing the results of invasive candidiasis prevention with anidulafungin vs. the lipid formulation of amphotericin B in high-risk patients in the early postoperative period after liver transplantation

Трансплантология (Москва), 2020
Introduction. The development of invasive candidiasis leads to high mortality after liver transplantation. Choosing an effective prophylaxis is an important task.The study purpose was to compare the results  of invasive candidiasis prevention with ...
S. V. Zhuravel, N. K. Kuznetsova, I. I. Utkina, M. S. Novruzbekov, P. V. Gavrilov, T. V. Chernenkaya, G. K. Ospanova   +6 more
doaj   +1 more source